Sirona Biochem Corp. (CVE:SBM – Get Free Report) shares traded down 27.8% during trading on Monday . The company traded as low as C$0.07 and last traded at C$0.07. 100,819 shares changed hands during mid-day trading, an increase of 26% from the average session volume of 79,998 shares. The stock had previously closed at C$0.09.
Sirona Biochem Stock Down 20.0 %
The company has a quick ratio of 2.41, a current ratio of 0.34 and a debt-to-equity ratio of 219.21. The stock has a 50-day simple moving average of C$0.05 and a two-hundred day simple moving average of C$0.06. The firm has a market cap of C$15.41 million, a PE ratio of -6.00 and a beta of -0.15.
Sirona Biochem Company Profile
Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, develops and sells cosmetic and pharmaceutical active ingredients in Canada and France. Its programs include cosmetic skin lightener and diabetes drug; and other projects comprise the development of an anti-aging/cell protection library, novel anti-wrinkle compound, and anti-viral program.
Featured Stories
- Five stocks we like better than Sirona Biochem
- What is the S&P/TSX Index?
- Goldilocks CPI Report Leads Market to Sell Off, Lower Lows Ahead
- Energy and Oil Stocks Explained
- GameStop: Earnings Won’t Save It, Dilution Points to Trouble
- Best Aerospace Stocks Investing
- Dividend Aristocrats or Dividend Kings: Which Is Best for You?
Receive News & Ratings for Sirona Biochem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sirona Biochem and related companies with MarketBeat.com's FREE daily email newsletter.
